Real World Data Analysis: Impact of High-Frequency REN Treatments as Migraine Preventive Therapy in Adolescence

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a post-marketing study investigating the safety and efficacy of the REN device (Nerivio by Theranica, ISRAEL) in adolescents with migraine. The data analysis will test the ability of Frequent use of REN for the acute treatment of migraine to reduce the number of monthly migraine days in subsequent months, suggesting potential preventive benefits.
Epistemonikos ID: 13966a14a774d1a44dee7b6d69b9fa5320c4e487
First added on: May 14, 2024